Galenica AG acquired Bahnhof Apotheke Langnau Ltd. from Manfred and Barbara Fankhauser for CHF 48 million on November 15, 2022. Under the terms, CHF 25.1 million was settled in cash and contingent consideration in the amount of CHF 22.9 million was recognised which is due in 2025 respectively in 2028 if certain financial and operational targets are achieved. With this acquisition, Galenica is also acquiring Cannaplant, the leading provider of formulations for medicinal cannabis products. Bahnhof Apotheke Langnau will continue to trade under its current name. Cannaplant and the pharmacy generated sales of around CHF 13 million in the last financial year. Pharmacy owner and pioneer in cannabis treatments, Manfred Fankhauser, and his wife, Barbara, will remain in management positions at the company. Manfred and Barbara will remain responsible for the company, and the employment relationships with its existing staff are being taken over by Galenica. Moritz Maurer, Janine Reudt-Demont and Markus Kronauer of Niederer Kraft Frey acted as the legal advisor to Bahnhof Apotheke Langnau.

Galenica AG completed the acquisition of Bahnhof Apotheke Langnau Ltd. from Manfred and Barbara Fankhauser on November 15, 2022.